Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea · Delayed Price · Currency is KRW 4,990.00
+50.00 (1.01%)
At close: Nov 13, 2026
Kyung Dong Pharmaceutical Market Cap
Kyung Dong Pharmaceutical has a market cap or net worth of 146.21 billion as of November 13, 2026. It is the 24,417th most valuable company in the world and the 991st biggest in South Korea. Its market cap has decreased by 6.92% in one year.
Market Cap
146.21B
Enterprise Value
144.44B
Revenue
201.12B
Global Rank
Country Rank
#991 South Korea
PE Ratio
7.71
ChartMarket Cap Chart
Since January 29, 2001, Kyung Dong Pharmaceutical's market cap has increased from 44.35B to 146.21B, an increase of 229.65%. That is a compound annual growth rate of 4.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 146.21B | -7.08% |
| Dec 30, 2025 | 157.34B | -4.73% |
| Dec 30, 2024 | 165.15B | -7.92% |
| Dec 28, 2023 | 179.35B | -16.01% |
| Dec 29, 2022 | 213.54B | -31.89% |
| Dec 30, 2021 | 313.54B | 1.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 227.13B |
| Vivozon Pharmaceutical | 179.59B |
| DAE HWA Pharmaceutical | 174.28B |
| GC WellBeing | 164.30B |
| CellBion | 157.06B |
| HEM Pharma | 156.44B |
| NOVAREX | 150.35B |
| PHARMARESEARCH BIO | 117.06B |